Journal article
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
Arteriosclerosis, thrombosis, and vascular biology, Vol.45(10), pp.e497-e511
10/2025
DOI: 10.1161/ATVBAHA.125.323072
PMCID: PMC12333561
PMID: 40740133
Abstract
Neutrophil infiltration exacerbates brain injury after subarachnoid hemorrhage (SAH). Integrin α9, expressed on neutrophils, facilitates their adhesion and transendothelial migration, leading to aggravated inflammatory responses and neuronal apoptosis. Insufficient clearance of apoptotic neurons by microglia and infiltrating blood-derived macrophages (defective efferocytosis) contributes to persistent inflammation and poor SAH recovery. This study investigated the role of neutrophil integrin α9 in neuronal apoptosis, microglia/macrophage efferocytosis, and SAH outcomes.
Neutrophil-specific
(
) and littermate control (
) mice were subjected to the endovascular perforation model to induce SAH. Sensorimotor and cognitive function were assessed for up to 4 weeks post-SAH using neurological severity score, corner and cylinder tests, Y-maze, and novel object recognition. In vitro and in vivo functional assays were conducted to assess the effect of integrin α9-dependent neutrophil transendothelial migration on efferocytosis of apoptotic neurons. Neutrophil infiltration, cerebral inflammation, neuronal apoptosis, and MMP (matrix metalloproteinase)-9 were quantified 24 hours post-SAH.
Mice subjected to SAH exhibited increased integrin α9 levels on infiltrated neutrophils compared with sham surgery controls. Neutrophil-specific
mice demonstrated improved long-term sensorimotor and cognitive recovery, reduced neutrophil infiltration, and decreased MMP-9 expression and neuronal apoptosis. Importantly, neutrophil-specific
mice exhibited reduced brain neutrophil elastase levels and enhanced efferocytosis. Mechanistic studies have revealed that the reduced transendothelial migration of
neutrophils directly contributed to the enhanced microglia/macrophage efferocytosis of apoptotic neurons. Pharmacological targeting of integrin α9 with macitentan significantly improved SAH outcomes by reducing neutrophil infiltration and enhancing efferocytosis. Comparable SAH outcomes in both macitentan-treated controls and neutrophil-specific
mice suggested that the therapeutic effects of macitentan were mediated by inhibition of neutrophil integrin α9.
Our study revealed a novel role for neutrophil integrin α9 in sensorimotor function and cognitive recovery after SAH, suggesting it as a potential therapeutic target for SAH.
Details
- Title: Subtitle
- Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
- Creators
- Harpreet Kaur - Louisiana State University Health Sciences Center ShreveportNilesh Pandey - Louisiana State University Health Sciences Center ShreveportLakshmi Chandaluri - Louisiana State University Health Sciences Center ShreveportNirvana Shaaban - Louisiana State University Health Sciences Center ShreveportDhananjay Kumar - Louisiana State University Health Sciences Center ShreveportRajan Pandit - Louisiana State University Health Sciences Center ShreveportAlexa Martinez - Louisiana State University Health Sciences Center ShreveportSumit Kumar Anand - Louisiana State University Health Sciences Center ShreveportSandeep Das - Louisiana State University Health Sciences Center ShreveportSumati Rohilla - Louisiana State University Health Sciences Center ShreveportFabio Arias - Louisiana State University Health Sciences Center ShreveportErika Reece - Louisiana State University Health Sciences Center ShreveportRavinder Reddy Gaddam - University of IowaKevin S Murnane - Louisiana State University Health Sciences Center ShreveportAjit Vikram - University of IowaRajesh Mohandas - Louisiana State University Health Sciences Center New OrleansXiaolu Zhang - Louisiana State University Health Sciences Center ShreveportMohammad Alfrad Nobel Bhuiyan - Louisiana State University Health Sciences Center ShreveportXiao-Hong Lu - Louisiana State University Health Sciences Center ShreveportA Wayne Orr - Louisiana State University Health Sciences Center ShreveportOren Rom - Louisiana State University Health Sciences Center ShreveportArif Yurdagul Jr - Louisiana State University Health Sciences Center ShreveportNirav Dhanesha - Louisiana State University Health Sciences Center Shreveport
- Resource Type
- Journal article
- Publication Details
- Arteriosclerosis, thrombosis, and vascular biology, Vol.45(10), pp.e497-e511
- DOI
- 10.1161/ATVBAHA.125.323072
- PMID
- 40740133
- PMCID
- PMC12333561
- NLM abbreviation
- Arterioscler Thromb Vasc Biol
- ISSN
- 1524-4636
- eISSN
- 1524-4636
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS; PHILADELPHIA
- Grant note
- National Institutes of Health: HL158546, HL150233, DK134011, DK136685, P20 GM121307, HL133497, HL141155, HL173972, HL167773, HL145131, HL167758 Career Development Award from American Heart Association: 23CDA1037711 AHA postdoctoral fellowship: 24POST1199551, 25POST1378188, 24POST1199805, 25POST1352845, 24POST1196650
This study was partially supported by the National Institutes of Health (HL158546 to N. Dhanesha, HL150233, DK134011, and DK136685 to O. Rom, P20 GM121307, HL133497, HL141155, HL173972 to A.W. Orr, HL167773 to A. Vikram, and HL145131 and HL167758 to A. Yurdagul Jr), Career Development Award from American Heart Association (AHA; 23CDA1037711 to R.R. Gaddam), the AHA postdoctoral fellowship 24POST1199551 (H. Kaur), 25POST1378188 (N. Pandey), 24POST1199805 (S.K. Anand), 25POST1352845 (D. Kumar), and 24POST1196650 (S. Das).
- Language
- English
- Electronic publication date
- 07/31/2025
- Date published
- 10/2025
- Academic Unit
- Cardiovascular Medicine; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9984927216802771
Metrics
13 Record Views